Global Multiple Sclerosis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Publisher Name :
Date: 21-Dec-2023
No. of pages: 118

Market Overview of Global Multiple Sclerosis market:

According to our latest research, the global Multiple Sclerosis market looks promising in the next 5 years. As of 2022, the global Multiple Sclerosis market was estimated at USD 13809.22 million, and it's anticipated to reach USD 21672.55 million in 2028, with a CAGR of 7.8% during the forecast years.

Multiple sclerosis (MS) is a chronic inflammatory neuropathy characterized by demyelination, axonal transection, and neurodegeneration in the central nervous system.

This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Multiple Sclerosis market, with a systematical description of the status quo and trends of the whole market, a close look into the competitive landscape of the major players, and a detailed elaboration on segment markets by type, by application and by region.

Key Takeaways from the Global Multiple Sclerosis Market Report:

Market Size Estimates: Multiple Sclerosis market size estimation in terms of value and sales volume from 2018-2028

Market Trends and Dynamics: Multiple Sclerosis market drivers, opportunities, challenges, and risks

Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Multiple Sclerosis market

Segment Market Analysis: Multiple Sclerosis market value and sales volume by type and by application from 2018-2028

Regional Market Analysis: Multiple Sclerosis market situations and prospects in North America, Asia Pacific, Europe, Latin America, Middle East, Africa

Country-level Studies on the Multiple Sclerosis Market: Revenue and sales volume of major countries in each region

Multiple Sclerosis Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product profile and application, etc.

Trade Flow: Import and export volume of the Multiple Sclerosis market in major regions.

Multiple Sclerosis Industry Value Chain: Multiple Sclerosis market raw materials & suppliers, manufacturing process, distributors, downstream customers

Multiple Sclerosis Industry News, Policies & Regulations

Key players in the global Multiple Sclerosis market are covered in Chapter 12:

TG Therapeutics

Bayer

Celgene

MediciNova

Roche

Novartis

Antisense Therapeutics

Merck KGaA

Teva

AB Science

GeNeuro

Santhera Pharmaceuticals

Biogen

Alkermes

InnoBioscience

GSK

Actelion

AbbVie

MedDay

Coherus Bioscience

Sanofi

Ionis Pharmaceutical

In Chapter 2 and Chapter 15.1, based on types, the Multiple Sclerosis market from 2018 to 2028 is primarily split into:

Injectable Agents

Oral Agents

In Chapter 3 and Chapter 15.2, based on applications, the Multiple Sclerosis market from 2018 to 2028 covers:

Hospital

Research

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 7, 8, 9, 10, 11, 15.3, 15.4:

North America (Covered in Chapter 7)

United States

Canada

Asia-Pacific (Covered in Chapter 8)

China

Japan

India

South Korea

Southeast Asia

Australia

Others

Europe (Covered in Chapter 9)

Germany

France

UK

Italy

Spain

Russia

Poland

Others

Latin America (Covered in Chapter 10)

Mexico

Brazil

Argentina

Others

Middle East and Africa (Covered in Chapter 11)

GCC Countries

Africa

Others

The data of this research report is mainly obtained from industry associations, magazines, press releases, national customs, annual reports of enterprises, expert interviews, paid databases and other channels with authority. It also provides scientific forecasts of the industry's core development indicators through professional analysis and forecasting models.

In short, whatever role you take in this industry value chain, this report will help you or your company to acquire a systematic and in-depth understanding of the industry.

Chapter Outline

This report consists of 16 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:

Chapter 1 starts the report with an overview of the Multiple Sclerosis market, as well as the definitions of the target market and the subdivisions. Through the presented global market size, regional market sizes, and segment market shares, you will be able to draw an overall and comprehensive picture of the market situation. Meanwhile, the research method and data source will be shared in this chapter.

Chapter 2 and Chapter 3 breaks down the market by different types and applications, with historic data presented in metrics of sales volume, revenue, market share and growth rate.

Chapter 4 elaborates on market dynamics and future trends in the industry, which contains an in-depth analysis of market drivers, opportunities, challenges, and risks. Other essential factors that will have a major impact on the market, i.e., industry news and policies in recent years, global inflation, and regional conflict, are also taken into consideration.

Chapter 5 compares the sales volume and revenue of the major regions across the globe, which enables the readers to understand the regional competitive pattern.

Chapter 6 is the analysis of the trade flow. Import volume and export volume are revealed on a regional level.

Chapters 7-11 focus on country-level studies. Data from the major countries in each region are provided, showing the current development of the industry in different countries. Besides, you will also find qualitative trends analysis under global inflation under each of the 6 regions.

Chapter 12 first up presents the competitive landscape by displaying and comparing the revenues, sales volumes, and market shares of the top players in the market, followed by a company-by-company analysis of all the major market participants with introductions of their products, product applications, company profiles, and business overview. In addition, their competitiveness is manifested through numbers of sales volume, revenue, price, gross and gross margin.

Chapter 13 looks into the whole market industrial chain, ranging from the upstream key raw materials and their suppliers to midstream distributors and downstream customers, with influences of global inflation taken into consideration.

Chapter 14 is perfect for those who wish to develop new projects in the industry. This chapter sheds a light on industry entry barriers and gives suggestions on new project investments.

Chapter 15 forecasts the future trend of the market from the perspective of different types, applications, and major regions.

Chapter 16 is the conclusion of the report which helps the readers sum up the main findings and insights.

Years considered for this report:

Historical Years: 2018-2022

Base Year: 2022

Estimated Year: 2023

Forecast Period: 2023-2028

Global Multiple Sclerosis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Table of Content

1 Multiple Sclerosis Market Overview
1.1 Product Overview
1.2 Market Segmentation
1.2.1 Market by Types
1.2.2 Market by Applications
1.2.3 Market by Regions
1.3 Global Multiple Sclerosis Market Size (2018-2028)
1.3.1 Global Multiple Sclerosis Revenue ($) and Growth Rate (2018-2028)
1.3.2 Global Multiple Sclerosis Sales Volume and Growth Rate (2018-2028)
1.4 Research Method and Logic
1.4.1 Research Method
1.4.2 Research Data Source

2 Global Multiple Sclerosis Market Historic Revenue ($) and Sales Volume Segment by Type
2.1 Global Multiple Sclerosis Historic Revenue ($) by Type (2018-2023)
2.2 Global Multiple Sclerosis Historic Sales Volume by Type (2018-2023)
2.3 Injectable Agents Sales and Price (2018-2023)
2.4 Oral Agents Sales and Price (2018-2023)

3 Global Multiple Sclerosis Historic Revenue ($) and Sales Volume by Application (2018-2023)
3.1 Global Multiple Sclerosis Historic Revenue ($) by Application (2018-2023)
3.2 Global Multiple Sclerosis Historic Sales Volume by Application (2018-2023)
3.3 Hospital Sales, Revenue and Growth Rate (2018-2023)
3.4 Research Sales, Revenue and Growth Rate (2018-2023)

4 Market Dynamic and Trends
4.1 Industry Development Trends under Global Inflation
4.2 Impact of Russia and Ukraine War
4.3 Driving Factors for Multiple Sclerosis Market
4.4 Factors Challenging the Market
4.5 Opportunities
4.6 Risk Analysis
4.7 Industry News and Policies by Regions
4.7.1 Multiple Sclerosis Industry News
4.7.2 Multiple Sclerosis Industry Policies

5 Global Multiple Sclerosis Market Revenue ($) and Sales Volume by Major Regions
5.1 Global Multiple Sclerosis Sales Volume by Region (2018-2023)
5.2 Global Multiple Sclerosis Market Revenue ($) by Region (2018-2023)

6 Global Multiple Sclerosis Import Volume and Export Volume by Major Regions
6.1 Global Multiple Sclerosis Import Volume by Region (2018-2023)
6.2 Global Multiple Sclerosis Export Volume by Region (2018-2023)

7 North America Multiple Sclerosis Market Current Status (2018-2023)
7.1 Overall Market Size Analysis (2018-2023)
7.1.1 North America Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
7.1.2 North America Multiple Sclerosis Sales Volume and Growth Rate (2018-2023)
7.2 North America Multiple Sclerosis Market Trends Analysis Under Global Inflation
7.3 North America Multiple Sclerosis Sales Volume and Revenue ($) by Country (2018-2023)
7.4 United States
7.4.1 United States Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
7.5 Canada
7.5.1 Canada Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)

8 Asia Pacific Multiple Sclerosis Market Current Status (2018-2023)
8.1 Overall Market Size Analysis (2018-2023)
8.1.1 Asia Pacific Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
8.1.2 Asia Pacific Multiple Sclerosis Sales Volume and Growth Rate (2018-2023)
8.2 Asia Pacific Multiple Sclerosis Market Trends Analysis Under Global Inflation
8.3 Asia Pacific Multiple Sclerosis Sales Volume and Revenue ($) by Country (2018-2023)
8.4 China
8.4.1 China Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
8.5 Japan
8.5.1 Japan Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
8.6 India
8.6.1 India Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
8.7 South Korea
8.7.1 South Korea Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
8.8 Southeast Asia
8.8.1 Southeast Asia Multiple Sclerosis Revenue ($) by Country (2018-2023)
8.9 Australia
8.9.1 Australia Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)

9 Europe Multiple Sclerosis Market Current Status (2018-2023)
9.1 Overall Market Size Analysis (2018-2023)
9.1.1 Europe Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
9.2.1 Europe Multiple Sclerosis Sales Volume and Growth Rate (2018-2023)
9.2 Europe Multiple Sclerosis Market Trends Analysis Under Global Inflation
9.3 Europe Multiple Sclerosis Sales Volume and Revenue ($) by Country (2018-2023)
9.4 Germany
9.4.1 Germany Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
9.5 France
9.5.1 France Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
9.6 United Kingdom
9.6.1 United Kingdom Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
9.7 Italy
9.7.1 Italy Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
9.8 Spain
9.8.1 Spain Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
9.9 Russia
9.9.1 Russia Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
9.10 Poland
9.10.1 Poland Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)

10 Latin America Multiple Sclerosis Market Current Status (2018-2023)
10.1 Overall Market Size Analysis (2018-2023)
10.1.1 Latin America Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
10.1.2 Latin America Multiple Sclerosis Sales Volume and Growth Rate (2018-2023)
10.2 Latin America Multiple Sclerosis Market Trends Analysis Under Global Inflation
10.3 Latin America Multiple Sclerosis Sales Volume and Revenue ($) by Country (2018-2023)
10.4 Mexico
10.4.1 Mexico Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
10.5 Brazil
10.5.1 Brazil Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
10.6 Argentina
10.6.1 Argentina Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)

11 Middle East and Africa Multiple Sclerosis Market Current Status (2018-2023)
11.1 Overall Market Size Analysis (2018-2023)
11.1.1 Middle East and Africa Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
11.2.1 Middle East and Africa Multiple Sclerosis Sales Volume and Growth Rate (2018-2023)
11.2 Middle East and Africa Multiple Sclerosis Market Trends Analysis Under Global Inflation
11.3 Middle East and Africa Multiple Sclerosis Sales Volume and Revenue ($) by Country (2018-2023)
11.4 GCC Countries
11.4.1 GCC Countries Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
11.5 Africa
11.5.1 Africa Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)

12 Market Competition Analysis and Key Companies Profiles
12.1 Market Competition by Key Players
12.1.1 Global Multiple Sclerosis Revenue ($) and Market Share of Key Players
12.1.2 Global Multiple Sclerosis Sales Volume and Market Share of Key Players
12.1.3 Global Multiple Sclerosis Average Price by Players
12.1.4 Mergers & Acquisitions, Expansion
12.2 TG Therapeutics Market Performance and Business Analysis
12.2.1 Company Profiles
12.2.2 Product Profiles and Application
12.2.3 TG Therapeutics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.3 Bayer Market Performance and Business Analysis
12.3.1 Company Profiles
12.3.2 Product Profiles and Application
12.3.3 Bayer Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.4 Celgene Market Performance and Business Analysis
12.4.1 Company Profiles
12.4.2 Product Profiles and Application
12.4.3 Celgene Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.5 MediciNova Market Performance and Business Analysis
12.5.1 Company Profiles
12.5.2 Product Profiles and Application
12.5.3 MediciNova Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.6 Roche Market Performance and Business Analysis
12.6.1 Company Profiles
12.6.2 Product Profiles and Application
12.6.3 Roche Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.7 Novartis Market Performance and Business Analysis
12.7.1 Company Profiles
12.7.2 Product Profiles and Application
12.7.3 Novartis Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.8 Antisense Therapeutics Market Performance and Business Analysis
12.8.1 Company Profiles
12.8.2 Product Profiles and Application
12.8.3 Antisense Therapeutics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.9 Merck KGaA Market Performance and Business Analysis
12.9.1 Company Profiles
12.9.2 Product Profiles and Application
12.9.3 Merck KGaA Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.10 Teva Market Performance and Business Analysis
12.10.1 Company Profiles
12.10.2 Product Profiles and Application
12.10.3 Teva Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.11 AB Science Market Performance and Business Analysis
12.11.1 Company Profiles
12.11.2 Product Profiles and Application
12.11.3 AB Science Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.12 GeNeuro Market Performance and Business Analysis
12.12.1 Company Profiles
12.12.2 Product Profiles and Application
12.12.3 GeNeuro Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.13 Santhera Pharmaceuticals Market Performance and Business Analysis
12.13.1 Company Profiles
12.13.2 Product Profiles and Application
12.13.3 Santhera Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.14 Biogen Market Performance and Business Analysis
12.14.1 Company Profiles
12.14.2 Product Profiles and Application
12.14.3 Biogen Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.15 Alkermes Market Performance and Business Analysis
12.15.1 Company Profiles
12.15.2 Product Profiles and Application
12.15.3 Alkermes Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.16 InnoBioscience Market Performance and Business Analysis
12.16.1 Company Profiles
12.16.2 Product Profiles and Application
12.16.3 InnoBioscience Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.17 GSK Market Performance and Business Analysis
12.17.1 Company Profiles
12.17.2 Product Profiles and Application
12.17.3 GSK Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.18 Actelion Market Performance and Business Analysis
12.18.1 Company Profiles
12.18.2 Product Profiles and Application
12.18.3 Actelion Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.19 AbbVie Market Performance and Business Analysis
12.19.1 Company Profiles
12.19.2 Product Profiles and Application
12.19.3 AbbVie Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.20 MedDay Market Performance and Business Analysis
12.20.1 Company Profiles
12.20.2 Product Profiles and Application
12.20.3 MedDay Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.21 Coherus Bioscience Market Performance and Business Analysis
12.21.1 Company Profiles
12.21.2 Product Profiles and Application
12.21.3 Coherus Bioscience Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.22 Sanofi Market Performance and Business Analysis
12.22.1 Company Profiles
12.22.2 Product Profiles and Application
12.22.3 Sanofi Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
12.23 Ionis Pharmaceutical Market Performance and Business Analysis
12.23.1 Company Profiles
12.23.2 Product Profiles and Application
12.23.3 Ionis Pharmaceutical Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)

13 Value Chain of the Multiple Sclerosis Market
13.1 Value Chain Status
13.1.1 Value Chain Status Under Global Inflation
13.2 Key Raw Materials and Suppliers
13.2.1 Key Raw Materials Introduction
13.2.2 Key Suppliers of Raw Materials
13.3 Manufacturing Cost Structure Analysis
13.3.1 Production Process Analysis
13.3.2 Manufacturing Cost Structure of Multiple Sclerosis
13.3.3 Raw Material Cost of Multiple Sclerosis
13.3.4 Labor Cost of Multiple Sclerosis
13.4 Major Distributors by Region
13.5 Customer Analysis

14 New Project Feasibility Analysis
14.1 Industry Barriers and New Entrants SWOT Analysis
14.2 Analysis and Suggestions on New Project Investment

15 Global Multiple Sclerosis Market Revenue ($) and Sales Volume Forecast Segment by Type, Application and Region
15.1 Global Multiple Sclerosis Revenue ($) and Sales Volume Forecast by Type (2023-2028)
15.1.1 Global Multiple Sclerosis Revenue ($) Forecast by Type (2023-2028)
15.1.2 Global Multiple Sclerosis Sales Volume Forecast by Type (2023-2028)
15.2 Global Multiple Sclerosis Revenue ($) and Sales Volume Forecast by Application (2023-2028)
15.2.1 Global Multiple Sclerosis Revenue ($) Forecast by Application (2023-2028)
15.2.2 Global Multiple Sclerosis Sales Volume Forecast by Application (2023-2028)
15.3 Global Multiple Sclerosis Sales Volume Forecast by Region (2023-2028)
15.4 Global Multiple Sclerosis Revenue ($) Forecast by Region (2023-2028)

16 Research Findings and Conclusion

List of Tables and Figures

Figure Multiple Sclerosis Picture
Table Multiple Sclerosis Definition
Table Description and Definitions
Figure Injectable Agents Features
Figure Oral Agents Features
Table Description and Definitions
Figure Hospital
Figure Research
Figure North America Multiple Sclerosis Revenue ($) and Growth Rate (2018-2028)
Figure Asia Pacific Multiple Sclerosis Revenue ($) and Growth Rate (2018-2028)
Figure Europe Multiple Sclerosis Revenue ($) and Growth Rate (2018-2028)
Figure Latin America Multiple Sclerosis Revenue ($) and Growth Rate (2018-2028)
Figure Middle East and Africa Multiple Sclerosis Revenue ($) and Growth Rate (2018-2028)
Figure Global Multiple Sclerosis Revenue ($) and Growth Rate (2018-2028)
Figure Global Multiple Sclerosis Sales Volume and Growth Rate (2018-2028)
Table Global Multiple Sclerosis Historic Revenue ($) by Type (2018-2023) (Million USD)
Table Global Multiple Sclerosis Historic Revenue ($) Share by Type (2018-2023)
Table Global Multiple Sclerosis Historic Sales Volume by Type (2018-2023)
Table Global Multiple Sclerosis Historic Sales Volume Share by Type (2018-2023)
Figure Global Injectable Agents Sales and Growth Rate (2018-2023)
Figure Global Injectable Agents Price (2018-2023)
Figure Global Oral Agents Sales and Growth Rate (2018-2023)
Figure Global Oral Agents Price (2018-2023)
Table Global Multiple Sclerosis Historic Revenue ($) by Application (2018-2023) (Million USD)
Table Global Multiple Sclerosis Historic Revenue ($) Share by Application (2018-2023)
Table Global Multiple Sclerosis Historic Sales Volume by Application (2018-2023) (Million USD)
Table Global Multiple Sclerosis Historic Sales Volume Share by Application (2018-2023)
Figure Global Hospital Sales and Growth Rate (2018-2023)
Figure Global Hospital Revenue and Growth Rate (2018-2023)
Figure Global Research Sales and Growth Rate (2018-2023)
Figure Global Research Revenue and Growth Rate (2018-2023)
Table Industry Development Trends under Global Inflation
Table Impact of Russia and Ukraine War
Table Driving Factors for Multiple Sclerosis Market
Table Factors Challenging the Market
Table Opportunities
Table Risk Analysis
Table Industry News by Regions
Table Industry Policies by Regions
Table Global Multiple Sclerosis Sales Volume by Region (2018-2023)
Table Global Multiple Sclerosis Sales Volume Share by Region (2018-2023)
Table Global Multiple Sclerosis Market Revenue ($) by Region (2018-2023)
Table Global Multiple Sclerosis Market Revenue ($) Share by Region (2018-2023)
Table Global Multiple Sclerosis Import Volume by Region (2018-2023)
Table Global Multiple Sclerosis Export Volume by Region (2018-2023)
Figure North America Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure North America Multiple Sclerosis Sales Volume and Growth Rate (2018-2023)
Table North America Multiple Sclerosis Market Trends Analysis Under Global Inflation
Table North America Multiple Sclerosis Revenue ($) by Country (2018-2023)
Table North America Multiple Sclerosis Sales Volume by Country (2018-2023)
Figure United States Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Canada Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Asia Pacific Multiple Sclerosis Sales Volume and Growth Rate (2018-2023)
Table Asia Pacific Multiple Sclerosis Market Trends Analysis Under Global Inflation
Table Asia Pacific Multiple Sclerosis Revenue ($) by Country (2018-2023)
Table Asia Pacific Multiple Sclerosis Sales Volume by Country (2018-2023)
Figure China Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Japan Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure India Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure South Korea Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Table Southeast Asia Multiple Sclerosis Revenue ($) by Country (2018-2023)
Figure Australia Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Europe Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Europe Multiple Sclerosis Sales Volume and Growth Rate (2018-2023)
Table Europe Multiple Sclerosis Market Trends Analysis Under Global Inflation
Table Europe Multiple Sclerosis Revenue ($) by Country (2018-2023)
Table Europe Multiple Sclerosis Sales Volume by Country (2018-2023)
Figure Germany Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure France Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure United Kingdom Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Italy Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Spain Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Russia Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Poland Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Latin America Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Latin America Multiple Sclerosis Sales Volume and Growth Rate (2018-2023)
Table Latin America Multiple Sclerosis Market Trends Analysis Under Global Inflation
Table Latin America Multiple Sclerosis Revenue ($) by Country (2018-2023)
Table Latin America Multiple Sclerosis Sales Volume by Country (2018-2023)
Figure Mexico Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Brazil Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Argentina Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Middle East and Africa Multiple Sclerosis Sales Volume and Growth Rate (2018-2023)
Table Middle East and Africa Multiple Sclerosis Market Trends Analysis Under Global Inflation
Table Middle East and Africa Multiple Sclerosis Revenue ($) by Country (2018-2023)
Table Middle East and Africa Multiple Sclerosis Sales Volume by Country (2018-2023)
Figure GCC Countries Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Figure Africa Multiple Sclerosis Revenue ($) and Growth Rate (2018-2023)
Table Global Multiple Sclerosis Revenue ($) of Key Players (2018-2023)
Table Global Multiple Sclerosis Revenue ($) Share of Key Players (2018-2023)
Table Global Multiple Sclerosis Sales Volume of Key Players (2018-2023)
Table Global Multiple Sclerosis Sales Volume Share of Key Players (2018-2023)
Table Global Multiple Sclerosis Average Price of Key Players (2018-2023)
Table Mergers & Acquisitions, Expansion Plans
Table TG Therapeutics Company Profiles
Table Product Profiles and Application
Table TG Therapeutics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure TG Therapeutics Production and Growth Rate
Figure TG Therapeutics Value ($) Market Share 2018-2023
Table Bayer Company Profiles
Table Product Profiles and Application
Table Bayer Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Bayer Production and Growth Rate
Figure Bayer Value ($) Market Share 2018-2023
Table Celgene Company Profiles
Table Product Profiles and Application
Table Celgene Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Celgene Production and Growth Rate
Figure Celgene Value ($) Market Share 2018-2023
Table MediciNova Company Profiles
Table Product Profiles and Application
Table MediciNova Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure MediciNova Production and Growth Rate
Figure MediciNova Value ($) Market Share 2018-2023
Table Roche Company Profiles
Table Product Profiles and Application
Table Roche Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Roche Production and Growth Rate
Figure Roche Value ($) Market Share 2018-2023
Table Novartis Company Profiles
Table Product Profiles and Application
Table Novartis Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2018-2023
Table Antisense Therapeutics Company Profiles
Table Product Profiles and Application
Table Antisense Therapeutics Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Antisense Therapeutics Production and Growth Rate
Figure Antisense Therapeutics Value ($) Market Share 2018-2023
Table Merck KGaA Company Profiles
Table Product Profiles and Application
Table Merck KGaA Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Merck KGaA Production and Growth Rate
Figure Merck KGaA Value ($) Market Share 2018-2023
Table Teva Company Profiles
Table Product Profiles and Application
Table Teva Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Teva Production and Growth Rate
Figure Teva Value ($) Market Share 2018-2023
Table AB Science Company Profiles
Table Product Profiles and Application
Table AB Science Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure AB Science Production and Growth Rate
Figure AB Science Value ($) Market Share 2018-2023
Table GeNeuro Company Profiles
Table Product Profiles and Application
Table GeNeuro Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure GeNeuro Production and Growth Rate
Figure GeNeuro Value ($) Market Share 2018-2023
Table Santhera Pharmaceuticals Company Profiles
Table Product Profiles and Application
Table Santhera Pharmaceuticals Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Santhera Pharmaceuticals Production and Growth Rate
Figure Santhera Pharmaceuticals Value ($) Market Share 2018-2023
Table Biogen Company Profiles
Table Product Profiles and Application
Table Biogen Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Biogen Production and Growth Rate
Figure Biogen Value ($) Market Share 2018-2023
Table Alkermes Company Profiles
Table Product Profiles and Application
Table Alkermes Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Alkermes Production and Growth Rate
Figure Alkermes Value ($) Market Share 2018-2023
Table InnoBioscience Company Profiles
Table Product Profiles and Application
Table InnoBioscience Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure InnoBioscience Production and Growth Rate
Figure InnoBioscience Value ($) Market Share 2018-2023
Table GSK Company Profiles
Table Product Profiles and Application
Table GSK Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure GSK Production and Growth Rate
Figure GSK Value ($) Market Share 2018-2023
Table Actelion Company Profiles
Table Product Profiles and Application
Table Actelion Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Actelion Production and Growth Rate
Figure Actelion Value ($) Market Share 2018-2023
Table AbbVie Company Profiles
Table Product Profiles and Application
Table AbbVie Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure AbbVie Production and Growth Rate
Figure AbbVie Value ($) Market Share 2018-2023
Table MedDay Company Profiles
Table Product Profiles and Application
Table MedDay Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure MedDay Production and Growth Rate
Figure MedDay Value ($) Market Share 2018-2023
Table Coherus Bioscience Company Profiles
Table Product Profiles and Application
Table Coherus Bioscience Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Coherus Bioscience Production and Growth Rate
Figure Coherus Bioscience Value ($) Market Share 2018-2023
Table Sanofi Company Profiles
Table Product Profiles and Application
Table Sanofi Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Sanofi Production and Growth Rate
Figure Sanofi Value ($) Market Share 2018-2023
Table Ionis Pharmaceutical Company Profiles
Table Product Profiles and Application
Table Ionis Pharmaceutical Market Performance Analysis (Revenue ($), Sales Volume, Price, Gross, Gross Margin)
Figure Ionis Pharmaceutical Production and Growth Rate
Figure Ionis Pharmaceutical Value ($) Market Share 2018-2023
Figure Industry Chain Analysis of Multiple Sclerosis
Table Value Chain Status Under Global Inflation
Table Key Raw Materials Introduction
Table Upstream Raw Material Suppliers of Multiple Sclerosis with Contact Information
Figure Production Process of Multiple Sclerosis
Figure Manufacturing Cost Structure of Multiple Sclerosis
Table Major Distributors of Multiple Sclerosis with Contact Information
Table Major Downstream Buyers of Multiple Sclerosis with Contact Information
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Table Global Multiple Sclerosis Revenue ($) Forecast by Type (2023-2028) (Million USD)
Table Global Multiple Sclerosis Revenue ($) Share Forecast by Type (2023-2028)
Table Global Multiple Sclerosis Sales Volume Forecast by Type (2023-2028) (Million USD)
Table Global Multiple Sclerosis Sales Volume Share Forecast by Type (2023-2028)
Table Global Multiple Sclerosis Revenue ($) Forecast by Application (2023-2028) (Million USD)
Table Global Multiple Sclerosis Revenue ($) Share Forecast by Application (2023-2028)
Table Global Multiple Sclerosis Sales Volume Forecast by Application (2023-2028) (Million USD)
Table Global Multiple Sclerosis Sales Volume Share Forecast by Application (2023-2028)
Table Global Multiple Sclerosis Sales Volume Forecast by Region (2023-2028)
Table Global Multiple Sclerosis Sales Volume Share Forecast by Region (2023-2028)
Table Global Multiple Sclerosis Revenue ($) Forecast by Region (2023-2028)
Table Global Multiple Sclerosis Revenue ($) Share Forecast by Region (2023-2028)
  • Global Fingolimod Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Fingolimod market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Fingolimod is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Fingolimod is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Multiple Sclerosis Drugs Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Multiple Sclerosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Multiple Sclerosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provi......
  • Global Multiple Sclerosis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Multiple Sclerosis market: According to our latest research, the global Multiple Sclerosis market looks promising in the next 5 years. As of 2022, the global Multiple Sclerosis market was estimated at USD 13809.22 million, and it's anticipated to reach USD 21672.55 million in 2028, with a CAGR of 7.8% during the forecast years. Multiple sclerosis (MS) is a chronic inflammatory neuropathy characterized by demyelination, axonal transection, and neurode......
  • Fingolimod - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 77
    The global Fingolimod market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Fingolimod in various end use industries. The expanding demands from the Medical Field, Science Research Field and Other Fields,, are propelling Fingolimod market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Inj......
  • Global Fingolimod Market Research Report 2023, Forecast to 2028
    Published: 19-Dec-2023        Price: US 2680 Onwards        Pages: 133
    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Global Fingolimod Professional Survey Report 2023, Forecast to 2028
    Published: 19-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) dat......
  • Multiple Sclerosis Drugs - Global Market Insights and Sales Trends 2024
    Published: 19-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Multiple Sclerosis Drugs, with both qu......
  • Global Multiple Sclerosis Drugs Market Research Report 2023
    Published: 25-Oct-2023        Price: US 2900 Onwards        Pages: 87
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multiple Sclerosis Drugs market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Biogen - Sanofi - Novartis - Teva - Merck KGaA - Bayer - ACORDA - Mallinckrodt Segment by Type - Injectable......
  • Global Multiple Sclerosis Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
    Published: 13-Jun-2023        Price: US 3260 Onwards        Pages: 122
    Multiple sclerosis (MS) is the most common disabling neurological disease in young people worldwide. The Multiple Sclerosis Drugs market revenue was 15099.44 Million USD in 2022, and will reach 23584.78 Million USD in 2028, with a CAGR of 7.72% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Multiple Sclerosis Drugs industry, and breaks down according to the type, application, and consumption area of Multiple Sclero......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs